CryoPort, a transport firm for the life science industry, has named Robert Stefanovich as chief financial officer (CFO), treasurer and corporate secretary. He has 20 years of experience in financial management, including more than a decade as a senior level financial executive in the healthcare and technology industries.
Most recently, Stefanovich served as CFO of Novalar Pharmaceuticals, a venture-backed specialty pharmaceutical company. Previously, he served as CFO with three publicly traded companies, including Xcorporeal, a medical device company; Artemis International Solutions, a software company; and Aethlon Medical, a medical device company. Before that, he was vice president of administration at SAIC, a Fortune 500 company.
Stefanovich also served as a member of the Software Advisory Group and an audit manager with Price Waterhouse’s (now PricewaterhouseCoopers) technology practice in San Jose, California and Frankfurt, Germany. He currently also serves as a board member of Project InVision International, a provider of business performance improvement solutions. He received his MBA and ME from University of Darmstadt in Germany.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.